Metabolic profiling for the detection of bladder cancer

Current Urology Reports

Volumn 12, Issue 1, 2011, Pages 34-40

  Van, Que N ^a   Veenstra, Timothy D ^a   Issaq, Haleem J ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

Biomarker detection; Bladder cancer; Chromatography; Mass spectrometry; Metabolomics; Nuclear magnetic resonance spectroscopy

Indexed keywords

3 AMINO 2 METHYLPROPIONIC ACID; CREATININE; PYROGLUTAMIC ACID; TAURINE;

ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CARCINOMA IN SITU; CREATININE URINE LEVEL; CYSTOSCOPY; DIAGNOSTIC VALUE; DISEASE MARKER; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; MASS SPECTROMETRY; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; URINARY BLADDER NEOPLASMS;

EID: 79551574144     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-010-0151-3     Document Type: Article

References (47)

1. AP Mitra RJ Cote 2010 Molecular screening for bladder cancer: progress and potential Nat Rev Urol 7 11 20 1:CAS:528:DC%2BC3cXjtlartQ%3D%3D 10.1038/nrurol.2009.236 20062071 The authors present a comprehensive review of the relative performance of major molecular tests for bladder cancer-specifying characteristics, sensitivity, and specificity
2. AS Ptolemy N Rifai 2010 What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation scheme Scand J Clin Lab Invest Suppl 242 6 14 10.3109/00365513.2010. 493354 20515269
3. C Schmidt 2004 Metabolomics takes its place as latest up-and-coming "omic" science J Natl Cancer Inst 96 732 734 10.1093/jnci/96.10.732 15150298
4. National Cancer Institute: Bladder Cancer Home Page. Available at http://www.cancer.gov/cancer-information/cancer-type/bladder. Accessed October 2010.
5. A Alvarez VB Lokeshwar 2007 Bladder cancer biomarkers: current developments and future implementation Curr Opin Urol 17 341 346 10.1097/MOU.0b013e3282c8c72b 17762628 (Pubitemid 47344622)
6. BR Konety 2006 Molecular markers in bladder cancer: a critical appraisal Urol Oncol 24 326 337 1:CAS:528:DC%2BD28Xms1Grtr0%3D 16818187 This article presents an excellent and informative discussion of molecular markers, pointing out the limitations, sensitivities, and specificities of each
7. DJ McConkey S Lee W Choi, et al. 2010 Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression Urol Oncol 28 429 440 1:CAS:528:DC%2BC3cXotVWksL8%3D 20610280
8. S Lintula K Hotakainen 2010 Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer Expert Opin Biol Ther 10 1169 1180 10.1517/14712598.2010.489546 20446896 This is an up-to-date discussion of bladder cancer biomarkers
9. RT Bryan MP Zeegers ND James, et al. 2010 Biomarkers in bladder cancer BJU Int 105 608 613 1:CAS:528:DC%2BC3cXktlSlt7c%3D 10.1111/j.1464-410X.2009. 08880.x 19793380
10. VL Robinson M Porter E Messing, et al. 2010 BCAN Think Tank session 2: Molecular detection of bladder cancer: The path to progress Urol Oncol 28 334 337 20439033
11. DI Ellis WB Dunn JL Griffin, et al. 2007 Metabolic fingerprinting as a diagnostic tool Pharmacogenomics 8 1243 1266 1:CAS:528:DC%2BD2sXhtlKhtrzF 10.2217/14622416.8.9.1243 17924839 (Pubitemid 47578232)
12. HJ Issaq O Nativ T Waybright, et al. 2008 Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry J Urol 179 2422 2426 1:CAS:528: DC%2BD1cXntlSmt7s%3D 10.1016/j.juro.2008.01.084 18433783
13. KK Pasikanti K Esuvaranathan PC Ho, et al. 2010 Noninvasive urinary metabonomic diagnosis of human bladder cancer J Proteome Res 9 2988 2995 1:CAS:528:DC%2BC3cXltFyktL4%3D 10.1021/pr901173v 20337499
14. 1H metabolic profiling study of human urine study for bladder-cancer biomarker discovery. Unfortunately, the authors only had access to a 400 MHz NMR spectrometer
15. K Kim P Aronov SO Zakharkin, et al. 2009 Urine metabolomics analysis for kidney cancer detection and biomarker discovery Mol Cell Proteomics 8 558 570 1:CAS:528:DC%2BD1MXjt12jtLk%3D 10.1074/mcp.M800165-MCP200 19008263
16. T Kind V Tolstikov O Fiehn RH Weiss 2007 A comprehensive urinary metabolomic approach for identifying kidney cancer Anal Biochem 363 185 195 1:CAS:528:DC%2BD2sXjsVWiurc%3D 10.1016/j.ab.2007.01.028 17316536 (Pubitemid 46428214)
17. 1H-NMR-based metabolomics Ernst Schering Found Symp Proc 4 205 226 10.1007/2789-2008-095 18811059
18. Oakman C, Tenori L, Biganzoli L, et al.: Uncovering the metabolomic fingerprint of breast cancer. Int J Biochem Cell Biol 2010 May 10 (Epub ahead of print).
19. S Urayama W Zou K Brooks V Tolstikov 2010 Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer Rapid Commun Mass Spectrom 24 613 620 1:CAS:528:DC%2BC3cXit1Snur0%3D 10.1002/rcm.4420 20143319
20. CM Rocha AS Barros AM Gil, et al. 2010 Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy J Proteome Res 9 319 332 1:CAS:528:DC%2BD1MXhsV2nurvF 10.1021/pr9006574 19908917
21. H Wu R Xue Z Tang, et al. 2010 Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry Anal Bioanal Chem 396 1385 1395 1:CAS:528:DC%2BD1MXhsFGmsLjE 10.1007/s00216-009-3317-4 20012946
22. H Wu R Xue C Lu, et al. 2009 Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 877 3111 3117 1:CAS:528:DC%2BD1MXhtFams7jP 10.1016/j.jchromb.2009.07.039 19716777
23. EC Chan PK Koh M Mal, et al. 2009 Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS) spectroscopy and gas chromatography mass spectrometry (GC/MS) J Proteome Res 8 352 361 1:CAS:528:DC%2BD1cXhsVOnsLnN 10.1021/pr8006232 19063642
24. B Feng F Yue MH Zheng 2009 Urinary markers in colorectal cancer Adv Clin Chem 47 45 57 1:CAS:528:DC%2BD1MXht1Wisr%2FI 10.1016/S0065-2423(09)47002-1 19634776
25. HM Woo KM Kim MH Choi, et al. 2009 Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers Clin Chim Acta 400 63 69 1:CAS:528:DC%2BD1MXht1Gmug%3D%3D 10.1016/j.cca.2008.10.014 19010317
26. JL Griffin JP Schokcor 2004 Metabolic profiles of cancer cells Nat Rev Cancer 4 551 561 1:CAS:528:DC%2BD2cXlt1Oktrk%3D 10.1038/nrc1390 15229480
27. C Hafner R Knuechel L Zanardo, et al. 2001 Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of upper and lower urinary tract Oncogene 20 4910 4915 1:CAS:528: DC%2BD3MXmtlCrsbk%3D 10.1038/sj.onc.1204671 11521204 (Pubitemid 32803163)
28. A Nordström E Want T Northen, et al. 2008 Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics Anal Chem 80 421 429 10.1021/ac701982e 18085752
29. TJ Waybright QN Van GM Muschik, et al. 2006 LC-MS in metabonomics: Optimization of experimental conditions for the analysis of metabolites in human urine J Liquid Chromatogr Related Technol 29 2475 2497 1:CAS:528: DC%2BD28Xht1Khu7fP 10.1080/10826070600914638 (Pubitemid 44359355)
30. MP Gonthier LY Rios M Verny, et al. 2003 Novel liquid chromatography-electrospray ionization mass spectrometry method for the quantification in human urine of microbial aromatic acid metabolites derived from dietary polyphenols J Chromatogr B Analyt Technol Biomed Life Sci 789 247 255 1:CAS:528:DC%2BD3sXjsVGhtrs%3D 10.1016/S1570-0232(03)00073-4 12742116 (Pubitemid 36549194)
31. EJ Want G O'Maille CA Smith, et al. 2006 Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry Anal Chem 78 743 752 1:CAS:528:DC%2BD28XhtFehurs%3D 10.1021/ac051312t 16448047 (Pubitemid 43228581)
32. A Sreekumar LM Poisson TM Rajendiran, et al. 2009 Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 457 910 914 1:CAS:528:DC%2BD1MXhslCnt70%3D 10.1038/nature07762 19212411
33. B Sitter TF Bathen MB Tessem IS Gribbestad 2009 High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer Prog Nucl Magn Reson Spectrosc 54 239 254 1:CAS:528:DC%2BD1MXjslOgtrk%3D 10.1016/j.pnmrs.2008.10.001
34. S Ma SK Chowdhury KB Alton 2006 Application of mass spectrometry for metabolite identification Curr Drug Metab 7 503 523 1:CAS:528: DC%2BD28XmtVajtb4%3D 10.2174/138920006777697891 16787159
35. O Beckonert HC Keun TM Ebbels, et al. 2007 Metabolic profiling, metabolomic and metabonomics procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts Nat Protoc 2 2692 2703 1:CAS:528:DC%2BD2sXhtlSlsr3E 10.1038/nprot.2007.376 18007604
36. HJ Issaq QN Van TJ Waybright, et al. 2009 Analytical and statistical approaches to metabolomics research J Sep Sci 32 2183 2199 1:CAS:528: DC%2BD1MXptVWrtbw%3D 10.1002/jssc.200900152 19569098
37. M Ghandforoush-Sattari S Mashayekhi 2008 Evaluation of taurine as a biomarker of liver damage in paracetamol poisoning Eur J Pharmacol 581 171 176 1:CAS:528:DC%2BD1cXhsVCmsrk%3D 10.1016/j.ejphar.2007.11.038 18086468
38. T Nakanishi Y Otaki Y Hasuike, et al. 2002 Association of hyperhomocysteinemia with plasma sulfate and urine sulfate excretion in patients with progressive renal disease Am J Kidney Dis 40 909 915 1:CAS:528: DC%2BD38XptVKgtL0%3D 10.1053/ajkd.2002.36320 12407634 (Pubitemid 35265469)
39. JH Winnike MG Busby PB Watkins TM O'Connell 2009 Effects of a prolonged standardized diet on normalizing the human metabolome Am J Clin Nutr 90 1496 1501 1:CAS:528:DC%2BD1MXhsV2lt7zJ 10.3945/ajcn.2009.28234 19864408
40. M Bayet-Robert D Loiseau P Rio A Demidem, et al. 2010 Quantitative two-dimensional HRMAS 1H-NMR spectroscopy-based metabolite profiling of human cancer cell lines and response to chemotherapy Magn Reson Med 63 1172 1183 1:CAS:528:DC%2BC3cXms1Cmsrc%3D 10.1002/mrm.22303 20432288
41. RK Rai P Tripathi N Sinha 2009 Quantification of metabolites from two-dimensional nuclear magnetic resonance spectroscopy: application to human urine samples Anal Chem 81 10232 10238 1:CAS:528:DC%2BD1MXhsVeis7vE 10.1021/ac902405z 19919088
42. 1H experiment
43. HJ Issaq E Abbott TD Veenstra 2008 Utility of separation science in metabolomic studies J Sep Sci 31 1936 1947 1:CAS:528:DC%2BD1cXos1equrY%3D 10.1002/jssc.200700601 18348322 This article presents a comprehensive discussion of different chromatographic and electrophoretic separation procedures for the analysis of the metabolome (Pubitemid 352003179)
44. ZY Liu JB Phillips 1991 Comprehensive two-dimensional gas chromatography using an on-column thermal modulator interface J Chromatogr Sci 29 227 231 1:CAS:528:DyaK3MXlt1Gqu70%3D
45. ID Wilson JK Nicholson J Castro-Perez, et al. 2005 High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies J Proteome Res 4 591 598 1:CAS:528: DC%2BD2MXisV2js7g%3D 10.1021/pr049769r 15822939 (Pubitemid 40548168)
46. EM Lenz ID Wilson 2007 Analytical strategies in metabonomics J Proteome Res 6 443 458 1:CAS:528:DC%2BD28Xht12qt7%2FM 10.1021/pr0605217 17269702 (Pubitemid 46340149)
47. JW Kim G Lee SM Moon, et al. 2010 Metabolic screening and star pattern recognition by urinary amino acid profile analysis from bladder cancer patients Metabolomics 6 202 206 1:CAS:528:DC%2BC3cXlsFSlsrw%3D 10.1007/s11306-010-0199-6